Suppr超能文献

眼用膜剂与成膜液体制剂增强眼部药物传递。

Ocular films versus film-forming liquid systems for enhanced ocular drug delivery.

机构信息

Department of Pharmaceutical Technology, Faculty of Pharmacy, Tanta University, Tanta, Egypt.

Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tanta University, Tanta, Egypt.

出版信息

Drug Deliv Transl Res. 2021 Jun;11(3):1084-1095. doi: 10.1007/s13346-020-00825-1.

Abstract

The short residence time, corneal barrier functions, and other effective eye protective mechanisms limited the ocular availability after topical application. Ocular inserts are being developed as polymer films for insertion into the conjunctival sac with the goal of increasing ocular availability. Unfortunately, these devices are not convenient for patients and are associated with many problems. The use of in situ gel/film-forming systems may provide promising alternative with comparable efficacy but this requires verification. Therefore, the current study compared ocular inserts with in situ film-forming liquids containing the same polymer components for ocular delivery of pilocarpine nitrate. Solvent casting technique was employed to prepare the inserts using and polyvinyl alcohol (PVA) as film-forming polymer blended with sodium alginate, as bioadhesive polymer. The effect of addition of either carboxymethycellulose, carbopol, polyvinylpyrrolidone, or methylcellulose was investigated. Solid-state characterization of the inserts indicated compatibility of the drug with film component. All inserts were of acceptable bioadhesive parameters and folding endurance that depended on the film composition. In vitro release studies reflected matrix diffusion kinetics for the film and liquid formulations. This confirms the in situ gelation of liquids. The calculated in vivo miotic pharmacokinetics parameters, using albino rabbits, reflected a better rank for the film but the difference was not statistically different from the in situ gel/film-forming systems. Ocular safety, as reflected by tear volume test, indicated acceptable safety of both liquid and inserts to the eye. The study suggested comparable efficacy of film-forming liquids to that of ocular films. Graphical abstract.

摘要

经眼部给药后,由于停留时间短、角膜屏障功能及其他有效的眼部保护机制,眼部的可用药物浓度有限。眼部插入物作为聚合物薄膜被开发出来,用于插入结膜囊,以增加眼部的药物可用性。然而,这些装置对患者来说并不方便,且存在许多问题。原位凝胶/成膜系统的应用可能是一种有前途的替代方法,具有相当的疗效,但这需要进一步验证。因此,本研究比较了含有相同聚合物成分的眼部插入物和原位成膜液,以用于硝酸毛果芸香碱的眼部给药。采用溶剂浇铸技术,以聚乙烯醇(PVA)为成膜聚合物,与海藻酸钠(生物粘附聚合物)混合,制备插入物。考察了添加羧甲基纤维素、卡波姆、聚乙烯吡咯烷酮或甲基纤维素的影响。插入物的固态特性表明药物与膜成分具有相容性。所有的插入物均具有可接受的生物粘附参数和折叠耐力,这取决于膜的组成。体外释放研究反映了膜和液体制剂的基质扩散动力学。这证实了液体的原位凝胶化。使用白化兔计算体内缩瞳药代动力学参数,反映了膜的更好等级,但与原位凝胶/成膜系统相比,差异无统计学意义。泪液体积测试反映的眼部安全性表明,液体和插入物对眼睛均具有可接受的安全性。该研究表明,成膜液与眼部薄膜具有相当的疗效。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验